Trials / Completed
CompletedNCT06148623
Clinical Performance Testing of Philips FAST SpO2 With Masimo Pulse Oximetry Sensors Across Skin Pigmentation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (actual)
- Sponsor
- Masimo Corporation · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Validate the performance of Philips FAST SpO2 with Masimo Pulse Oximetry Sensors in determining functional arterial oxygen saturation (SpO2) using arterial saturation (SaO2) as a reference in the range of 70-100% in subjects of varying skin pigmentation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Philips FAST SpO2 with Masimo Pulse Oximetry Sensors | Noninvasive pulse oximeter |
Timeline
- Start date
- 2023-11-13
- Primary completion
- 2025-01-14
- Completion
- 2025-01-14
- First posted
- 2023-11-28
- Last updated
- 2026-04-02
- Results posted
- 2026-03-11
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06148623. Inclusion in this directory is not an endorsement.